TRDA
Entrada Therapeutics, Inc. · Healthcare
MPM BIOVENTURES 2018, L.P. sold $616K of Entrada Therapeutics, Inc.
10% owner
Sold$615,777
$7.08Price
86,914Shares
−2%Stake
What TRDA did after the filing
- The stock from Tue, Sep 1 open, $6.95
- −34.5%
- S&P 500, same days
- +1.0%
Measured over 30 trading days, to the Oct 14 close.
Traded Thu, Aug 27. Filed Mon, Aug 31, 6:26 PM ET, after the close. Returns use the Sep 1 open and the Oct 14 close. Not investment advice.